Form D Explorer

Form C-AR — Cytex Therapeutics, Inc.

0001665160-25-000970 · filed 2025-05-02

Offering

Target
—
Maximum
—
Security type
—
Price per security
—
Deadline
—
Oversubscription
—

Issuer

Name
Cytex Therapeutics, Inc.
CIK
1943908
Entity
Corporation
Jurisdiction
DE
Address
2609 N. DUKE STREET, SUITE 303A
DURHAM, NC 27704
Phone
—

Most recent fiscal year financials

Total assets
$536,278
Cash
—
Short-term debt
$231,628
Long-term debt
$957,036
Revenues
$1,366,195
COGS
$985,982
Taxes paid
—
Net income
$-1,069,206

Same issuer's Form D filings

View original on SEC EDGAR.